GLP-1 medications are best known for appetite and weight effects, but reward and craving research is expanding. A timeline helps track what actually changed, when, and alongside what context.
Private logs for dose timing, food noise, alcohol cravings, mood, sleep, and side effects.
Evidence boundary: GLP-1s are not approved as addiction treatments. Human alcohol data is emerging; behavioral-urge data is much earlier. Use tracking as a memory aid, not as treatment.
Why track cravings over time?
Cravings are variable. They can shift with dose changes, nausea, sleep debt, alcohol, stress, appetite, travel, and mood. A craving timeline is useful because it keeps food noise, alcohol interest, gambling urges, and other reward-related notes in the same time window as the medication routine.
Signal
Simple tracking field
Food noise
0-10, plus whether it shows up at night, after stress, or before meals.
Low pleasure, flat mood, libido change, social withdrawal, fatigue.
Medication context
Dose day, dose-change week, missed dose, restart, side effects.
What the science supports
GLP-1 receptor agonists affect appetite and may influence reward pathways, which is why they are being studied for alcohol and other addictive disorders.
A 2025 randomized clinical trial evaluated once-weekly semaglutide in adults with alcohol use disorder. That is stronger evidence than anecdotes, but still not a reason to self-treat alcohol use disorder with a GLP-1.
For gambling or compulsive behaviors, evidence is much thinner. The safe page angle is urge tracking and harm reduction, not treatment claims.
Jabbit setup: Use one repeatable note template: craving 0-10, trigger, dose week, sleep, alcohol, mood, GI symptoms, action taken, and outcome.